Tesla’s retail sales in China surged after price cut
TESLA’S retail sales surged in China in January after it slashed prices for its top-selling models earlier in the month, data compiled by China Merchants Bank International (CMBI) showed.
Average daily sales for Tesla in China during the Jan 9 to Jan 15 period jumped 76 per cent from the same period in 2022 to 12,654 vehicles, CMBI’s data showed.
That compared to a 14.5 per cent year-on-year decline in overall retail auto sales in China in the same week, although sales of electric and hybrid vehicles in the country increased 36.5 per cent, the data showed.
Tesla didn’t immediately respond to a request for comment on CMBI’s data on its sales.
Tesla cut prices for the Model 3 and Model Y cars by between 6 per cent to 13.5 per cent in China from Jan 6 in the face of what analysts said were signs of faltering demand and intensifying competition in the world’s largest auto market.
After cutting prices in China and other Asian markets, Tesla followed with price cuts in the United States and Europe.
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Huawei Technologies-backed electric vehicle (EV) brand Aito and Xpeng have followed Tesla in reducing prices for their EVs in China.
Xpeng’s sales fell 36 per cent from a year earlier in the week of Jan 9 to Jan 15, CMBI data showed. Sales for Tesla’s larger EV rival in China, BYD, more than doubled in the week to 40,435 vehicles, including both its EVs and hybrids, the data showed. REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Asia stocks rise on Wednesday amid Wall Street rally; STI up 0.6%
Orsted says Taiwan wind project to power TSMC on track for 2025 finish
China knockoff raid jolts a global throng of fake-fashion influencers
Tesla profits tumble but shares rise on new vehicle plan
Brokers’ take: CGS International upgrades Nanofilm to ‘hold’ despite lower target price
Roche cuts pipeline after research setbacks and sales drop